Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tecnimede joins Spanish generics association

This article was originally published in Scrip

Executive Summary

The Tecnimede group is the 27thcompany to join AESEG, Spain's generic medicines association. The privately owned group is based in Portugal but has a presence in 30 markets and a portfolio of over 40 generic medicines. Tecnimede is made up of three companies that specialise in commercialisation – Tecnimede, Pentafarma and Farmoz; two production facilities – West Pharma and Atlantic Pharma; and an R&D plant – Labor Qualitas. AESEG represents pharmaceutical companies that develop, produce and market generic medicines and firms that produce active ingredients.

You may also be interested in...



Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

German HTA Queries Polivy Benefits Amid Lack Of Evidence

Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.

Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy

In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC030686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel